A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation
If Kaiser's formulary committee says no, your options within the system are limited
But do you know how long to charge an Airsoft battery
Other brain regions with GLP-1 receptor expression include: Ventral tegmental area and nucleus accumbens (reward and motivation circuits) Amygdala (emotional processing and stress responses) Prefrontal cortex (executive function and decision-making) Substantia nigra (motor control, relevant to Parkinson's disease research) This widespread distribution suggests that GLP-1 influences diverse neurological functions beyond appetite regulation
Cognition and mood does chronic appetite suppression alter dopamine tone, motivation, or emotional range
8.5 Extension to dual, triple-agonist and amylin-based co-agonist therapies The emergence of dual and multi-agonist therapies, such as the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide, raises important questions regarding the generalisability of the proposed framework
